{"count": 31, "results": [{"_id": "40537294", "pmid": 40537294, "title": "A Case of Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis.", "journal": "J Emerg Med", "authors": ["Tomita D", "Bamba Y", "Kuwabara N", "Akakabe S", "Matsubayashi Y", "Nakagawa S", "Sone H", "Nishiyama K"], "date": "2025-02-17T00:00:00Z", "doi": "10.1016/j.jemermed.2025.02.018", "meta_date_publication": "2025 Feb 17", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50269.562, "text_hl": "A Case of Concurrent @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@Lactic Acidosis@@@ and @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@Euglycemic Diabetic Ketoacidosis@@@.", "citations": {"NLM": "Tomita D, Bamba Y, Kuwabara N, Akakabe S, Matsubayashi Y, Nakagawa S, Sone H, Nishiyama K. A Case of Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis. J Emerg Med. 2025 Feb 17;():. PMID: 40537294", "BibTeX": "@article{40537294, title={A Case of Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis.}, author={Tomita D and Bamba Y and Kuwabara N and Akakabe S and Matsubayashi Y and Nakagawa S and Sone H and Nishiyama K}, journal={J Emerg Med}}"}}, {"_id": "36934381", "pmid": 36934381, "title": "Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.", "journal": "CEN Case Rep", "authors": ["Kuno H", "Fujimaru T", "Kadota N", "Konishi K", "Sekiguchi M", "Watanabe K", "Ito Y", "Nagahama M", "Taki F", "Hifumi T", "Otani N", "Nakayama M"], "date": "2023-03-19T00:00:00Z", "doi": "10.1007/s13730-023-00783-w", "meta_date_publication": "2023 Mar 19", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50265.85, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ is a well-known @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment complication; however, the development of euglycemic @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@diabetic ketoacidosis@@@ (@<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@euDKA@@@) has rarely been reported. ", "citations": {"NLM": "Kuno H, Fujimaru T, Kadota N, Konishi K, Sekiguchi M, Watanabe K, Ito Y, Nagahama M, Taki F, Hifumi T, Otani N, Nakayama M. Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose. CEN Case Rep. 2023 Mar 19;():. PMID: 36934381", "BibTeX": "@article{36934381, title={Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.}, author={Kuno H and Fujimaru T and Kadota N and Konishi K and Sekiguchi M and Watanabe K and Ito Y and Nagahama M and Taki F and Hifumi T and Otani N and Nakayama M}, journal={CEN Case Rep}}"}}, {"_id": "35707462", "pmid": 35707462, "pmcid": "PMC9190285", "title": "Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials", "journal": "Front Endocrinol (Lausanne)", "authors": ["Liu Y", "Chen H", "Li H", "Li L", "Wu J", "Li H"], "date": "2022-05-30T00:00:00Z", "doi": "10.3389/fendo.2022.878585", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "878585", "score": 50264.71, "text_hl": "However, no statistical difference was detected for the incidence of @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@DKA@@@, although a numerically higher incidence of @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@DKA@@@ occurred in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (RR=1.72, 95%CI=0.59 to 5.06, I2 = 0%) ( Figure 6 ).", "citations": {"NLM": "Liu Y, Chen H, Li H, Li L, Wu J, Li H. Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials Front Endocrinol (Lausanne). 2022;13():878585. PMID: 35707462", "BibTeX": "@article{35707462, title={Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials}, author={Liu Y and Chen H and Li H and Li L and Wu J and Li H}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={878585}}"}}, {"_id": "36189139", "pmid": 36189139, "pmcid": "PMC9508574", "title": "Diabetic Ketoacidosis Complicating Gestational Diabetes Mellitus", "journal": "AACE Clin Case Rep", "authors": ["Villavicencio CA", "Franco-Akel A", "Belokovskaya R"], "date": "2022-07-19T00:00:00Z", "doi": "10.1016/j.aace.2022.07.002", "meta_date_publication": "2022 Sep-Oct", "meta_volume": "8", "meta_issue": "5", "meta_pages": "221-223", "score": 50262.008, "text_hl": "@<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@Diabetic Ketoacidosis@@@ Complicating Gestational @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes Mellitus@@@", "citations": {"NLM": "Villavicencio CA, Franco-Akel A, Belokovskaya R. Diabetic Ketoacidosis Complicating Gestational Diabetes Mellitus AACE Clin Case Rep. 2022 Sep-Oct;8(5):221-223. PMID: 36189139", "BibTeX": "@article{36189139, title={Diabetic Ketoacidosis Complicating Gestational Diabetes Mellitus}, author={Villavicencio CA and Franco-Akel A and Belokovskaya R}, journal={AACE Clin Case Rep}, volume={8}, number={5}, pages={221-223}}"}}, {"_id": "38143642", "pmid": 38143642, "pmcid": "PMC10740381", "title": "\"Normal but Catastrophic\" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report", "journal": "Cureus", "authors": ["Sarno MJF", "Hernandez DPF", "Matulac MO"], "date": "2023-11-22T00:00:00Z", "doi": "10.7759/cureus.49236", "meta_date_publication": "2023 Nov", "meta_volume": "15", "meta_issue": "11", "meta_pages": "e49236", "score": 50261.887, "text_hl": "This is a case of a 34-year-old male, Filipino, diagnosed with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@, who was maintained on @CHEMICAL_dapagliflozin @CHEMICAL_MESH:C529054 @@@dapagliflozin@@@ + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 5mg/1000mg taken twice a day with good compliance and was admitted with @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@EuDKA@@@ precipitated by decreased food intake and managed with intravenous @GENE_INS @GENE_3630 @@@insulin@@@. ", "citations": {"NLM": "Sarno MJF, Hernandez DPF, Matulac MO. \"Normal but Catastrophic\" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report Cureus. 2023 Nov;15(11):e49236. PMID: 38143642", "BibTeX": "@article{38143642, title={\"Normal but Catastrophic\" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report}, author={Sarno MJF and Hernandez DPF and Matulac MO}, journal={Cureus}, volume={15}, number={11}, pages={e49236}}"}}, {"_id": "32855828", "pmid": 32855828, "pmcid": "PMC7443033", "title": "A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed", "journal": "Case Rep Endocrinol", "authors": ["Steinmetz-Wood S", "Gilbert M", "Menson K"], "date": "2020-08-13T00:00:00Z", "doi": "10.1155/2020/8832833", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "8832833", "score": 50261.527, "text_hl": "Another case reports a similar story of a 44-year-old man who had been on @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and an Atkins diet, and 3-4 days after starting @CHEMICAL_Canagliflozin @CHEMICAL_MESH:D000068896 @@@canagliflozin@@@, he developed euglycemic @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@DKA@@@ which was first missed by the @DISEASE_Emergencies @DISEASE_MESH:D004630 @@@ED@@@ and later recognized by his primary internist. ", "citations": {"NLM": "Steinmetz-Wood S, Gilbert M, Menson K. A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed Case Rep Endocrinol. 2020;2020():8832833. PMID: 32855828", "BibTeX": "@article{32855828, title={A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed}, author={Steinmetz-Wood S and Gilbert M and Menson K}, journal={Case Rep Endocrinol}, volume={2020}, pages={8832833}}"}}, {"_id": "37947121", "pmid": 37947121, "title": "The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study.", "journal": "Expert Opin Drug Saf", "authors": ["Zhao Q", "Tan Y", "Wu Q", "Xiao X", "Wei X", "Nian M", "Yao J", "Fan N", "Wang R", "Fan G"], "date": "2023-11-10T00:00:00Z", "doi": "10.1080/14740338.2023.2275704", "meta_date_publication": "2023 Nov 10", "meta_volume": "", "meta_issue": "", "meta_pages": "1-9", "score": 50260.79, "text_hl": "Multivariate logistic regression identified age <45 years [OR = 2.99, 95% CI (1.45-6.17)], concomitant use of @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@Acarbose@@@ [OR = 2.18, 95% CI (1.06-3.38)], @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ [OR = 1.84, 95% CI (1.01-3.38)], and @GENE_INS @GENE_3630 @@@Insulin@@@ [OR = 1.93, 95% CI (1.02-3.66)] as participating factors for @DISEASE_DK_Phocomelia_Syndrome @DISEASE_MESH:C565618 @@@DK@@@/@<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@DKA@@@. ", "citations": {"NLM": "Zhao Q, Tan Y, Wu Q, Xiao X, Wei X, Nian M, Yao J, Fan N, Wang R, Fan G. The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study. Expert Opin Drug Saf. 2023 Nov 10;():1-9. PMID: 37947121", "BibTeX": "@article{37947121, title={The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study.}, author={Zhao Q and Tan Y and Wu Q and Xiao X and Wei X and Nian M and Yao J and Fan N and Wang R and Fan G}, journal={Expert Opin Drug Saf}, pages={1-9}}"}}, {"_id": "37424794", "pmid": 37424794, "pmcid": "PMC10325753", "title": "Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure", "journal": "Cardiovasc Endocrinol Metab", "authors": ["Nzomessi D", "Massie E", "Gariani K", "Giraud R", "Meyer P"], "date": "2023-07-04T00:00:00Z", "doi": "10.1097/XCE.0000000000000287", "meta_date_publication": "2023 Sep", "meta_volume": "12", "meta_issue": "3", "meta_pages": "e0287", "score": 50258.72, "text_hl": "Very few cases in the literature describe the combination of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@ and @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@EDKA@@@ in @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and SGLT2i. ", "citations": {"NLM": "Nzomessi D, Massie E, Gariani K, Giraud R, Meyer P. Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure Cardiovasc Endocrinol Metab. 2023 Sep;12(3):e0287. PMID: 37424794", "BibTeX": "@article{37424794, title={Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure}, author={Nzomessi D and Massie E and Gariani K and Giraud R and Meyer P}, journal={Cardiovasc Endocrinol Metab}, volume={12}, number={3}, pages={e0287}}"}}, {"_id": "34169619", "pmid": 34169619, "title": "Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care.", "journal": "Diabetes Obes Metab", "authors": ["Fralick M", "Schneeweiss S", "Redelmeier DA", "Razak F", "Gomes T", "Patorno E"], "date": "2021-10-01T00:00:00Z", "doi": "10.1111/dom.14474", "meta_date_publication": "2021 Oct", "meta_volume": "23", "meta_issue": "10", "meta_pages": "2320-2328", "score": 50253.6, "text_hl": "The rates of @DISEASE_Infections @DISEASE_MESH:D007239 @@@genital infection@@@ (HR 2.28, 95% CI 1.87, 2.78) and @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@diabetic ketoacidosis@@@ (HR 1.58, 95% CI 0.92, 2.70) were higher for @SPECIES_9606 @@@patients@@@ prescribed an SGLT2 inhibitor compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, while the rates of @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@acute kidney injury@@@ (HR 0.94, 95% CI 0.60, 1.47) or hypoglycaemia (HR 0.83, 95% CI 0.48, 1.42) were not. ", "citations": {"NLM": "Fralick M, Schneeweiss S, Redelmeier DA, Razak F, Gomes T, Patorno E. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care. Diabetes Obes Metab. 2021 Oct;23(10):2320-2328. PMID: 34169619", "BibTeX": "@article{34169619, title={Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care.}, author={Fralick M and Schneeweiss S and Redelmeier DA and Razak F and Gomes T and Patorno E}, journal={Diabetes Obes Metab}, volume={23}, number={10}, pages={2320-2328}}"}}, {"_id": "33628041", "pmid": 33628041, "pmcid": "PMC7899305", "title": "A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma", "journal": "Diabetes Metab Syndr Obes", "authors": ["Wu L", "Li B"], "date": "2021-02-18T00:00:00Z", "doi": "10.2147/DMSO.S297709", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "753-757", "score": 50252.32, "text_hl": "Upon resolution of her @<m>DISEASE_Diabetic_Ketoacidosis</m> @DISEASE_MESH:D016883 @@@DKA@@@, she continued to require @GENE_INS @GENE_3630 @@@insulin@@@ therapy in addition to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ given.", "citations": {"NLM": "Wu L, Li B. A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma Diabetes Metab Syndr Obes. 2021;14():753-757. PMID: 33628041", "BibTeX": "@article{33628041, title={A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma}, author={Wu L and Li B}, journal={Diabetes Metab Syndr Obes}, volume={14}, pages={753-757}}"}}]}